Oxpentyfylline did not improve Parkinson's disease symptoms in a small trial. Unexpectedly, most patients experienced worsening or new involuntary movements, suggesting potential adverse effects.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: